Both a low- and a high-dose modified epoetin alfa regimen were effective compared with placebo in reducing allogeneic transfusions in patients undergoing hip arthroplasty. Patients who received high-dose epoetin alfa had the lowest transfusion rate.
Topics:
iron, erythropoietin, hemoglobin, blood transfusion, epoetin alfa, hip joint, arthroplasty, transfusion
Ann Intern Med. 2000;133(11):845-854. doi:10.7326/0003-4819-133-11-200012050-00008